spacer
home > ict > spring 2016 > across the globe
PUBLICATIONS
International Clinical Trials

Across the Globe

The purpose of clinical trials is, simply put, to evaluate the effects of a drug on trial participants. It makes sense to involve participants from as many ethnic groups as possible, in order to assess the drug’s efficacy and announce it as safe for the public to use.

However, despite continuous efforts to globalise these trials, developing countries are still under-represented in clinical research – and there are a number of factors contributing to this siuation, like the lack of commercial viability and trained researchers, for example (1). Why is this contradictory? For one, the sheer population numbers in these countries means that there is a bigger patient pool available than in developed countries; furthermore, these potential patients might also be more willing to participate in a trial, and – in what is perhaps the most significant benefit of carrying out trials in remote locations – they can be recruited at substantially less cost compared to more affluent countries, as well as at a much faster rate (2).

References
1. Visit: www.journals.plos.org/plosmedicine/article?id=10.1371/ journal.pmed.1001228
2. Visit: www.fda.gov/downloads/training/ clinicalinvestigatortrainingcourse/ucm378499.pdf

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

Blockbuster Drugs Need Blockbuster Components

West Pharmaceutical Services, Inc.

Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement